Kästner C, Zott H J, Wallrabe D
Medizinischen Klinik, Krankenhauses der Volkspolizei Berlin.
Z Gesamte Inn Med. 1989 Aug 1;44(15):442-5.
In 10 male hypertensives without therapy who were active in sports echocardiographic examinations at rest, during and after a dynamic exercise were performed 1 hour after oral administration of 100 mg of propranolol and 6 weeks after a daily administration of 3 X 25 mg of propranolol. For comparison the results of 51 normotensive males of the same age were at disposal. The effects of propranolol in the acute experiment and under a permanent therapy are demonstrated at the parameters heart rate, systolic blood pressure, mean arterial pressure, end-diastolic volume index, stroke-volume index, ejection fraction, frequence-normed mean circumferential speed of shortening of fibres and peripheral resistance. In consequence of the effective decrease of blood pressure at rest and on exertion and lacking negatively inotropic effects on the contractility and pumping function at rest and on exertion during a permanent therapy the application of the beta-blockers in the antihypertensive therapy of bodily active hypertensives is to be recommended. From the behavior of the peripheral resistance under a vermanent therapy is concluded that a combination with a pasodilator is not necessary.
对10名未经治疗但积极运动的男性高血压患者进行了研究。在口服100毫克普萘洛尔1小时后以及每日服用3×25毫克普萘洛尔6周后,分别在静息状态、动态运动期间及运动后进行了超声心动图检查。作为对照,可获取51名同年龄正常血压男性的检查结果。通过心率、收缩压、平均动脉压、舒张末期容积指数、每搏输出量指数、射血分数、频率标准化的纤维平均周向缩短速度以及外周阻力等参数,展示了普萘洛尔在急性实验和长期治疗中的效果。由于在长期治疗中,静息及运动时血压有效降低,且对静息及运动时的收缩性和泵血功能无负性肌力作用,因此推荐在身体活跃的高血压患者的抗高血压治疗中应用β受体阻滞剂。从长期治疗中外周阻力的表现可以得出结论,无需与血管扩张剂联合使用。